- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in astrazeneca pharma
AstraZeneca Turning To Biogas To Cut US Carbon Emissions
Drugmaker AstraZeneca is switching to biogas produced from cow manure and food waste in the United States, it said on Tuesday, in a deal to cut its carbon emissions there
Read More
AstraZeneca India Appoints Bhavana Agrawal As CFO With Effect From October
AstraZeneca Pharma India, a leading biopharmaceutical company, announced the appointment of Bhavana Agrawal as Chief Finance Officer (CFO) with effect from October 1, 2023, following a transition period. She succeeds Rajesh Marwaha, who is retiring as CFO and full-time director of the Company from the close of business hours on September 30, 2023
Read More
AstraZeneca Says Imfinzi Combo Reflects Hope In Late-stage Lung Cancer Trial
Imfinzi belongs to the immunotherapy class of treatments, which boost the body's defences to fight cancer by using antibodies that block or bind to foreign substances in the body. The treatment generated $2.41 billion in 2021 sales
Read More
AstraZeneca To Apply For Covid-19 Vaccine Approval In US Later In 2021
The timeline for the USFDA application has been in the works since the end-March when AstraZeneca released the data from its clinical trials of the COVID-19 vaccine in the US.
Read More
Getting Free, Affordable and Quality Healthcare is a Fundamental Right: Adar Poonawalla
It is now very clear that if you wait two and a half to three months between the first and the second dose, the efficacy is more than 80 per cent for the Oxford-AstraZeneca product
Read More
AstraZeneca Gets DCGI Nod For Asthma Drug
The company has received approval from the DCGI for Fasenra (Benralizumab solution for injection in a single dose prefilled syringe30 mg/ml) for patients with severe asthma (eosinophilic asthma)
Read More
AstraZeneca Pharma Gets DCGI Nod To Market Asthma Drug
AstraZeneca Pharma said the receipt of this permission paves way for the launch of Benralizumab (Fasenra) in India, subject to the receipt of related statutory approvals and licenses.
Read More
AstraZeneca Must Prove Claim To Cheapest COVID-19 Vaccine
AstraZeneca has said it will not profit from sales of its vaccine, the price of which has been set at about $3 per dose, against at least four times more for other candidates.
Read More
AstraZeneca's COVID-19 Vaccine To Begin Clinical Trials In China
The vaccine candidate is already in the final stage of clinical trials in other countries, and AstraZeneca and its partner on the project, the University of Oxford, expect data from the late-stage trials this year.
Read More
Global Shares Slip As Coronavirus Worries Overshadow Positive China Data
The broader Euro STOXX 600 fell 0.4% in early trading, with bourses in Frankfurt, London and Paris all down by a similar margin.
Read More
EU Agency Recommends AstraZeneca-Merck Drug Lynparza For Two Cancers
Prostate cancer is the second-most common type of cancer in men worldwide, while ovarian cancer is the fifth most common cause of cancer death in Europe.
Read More
AstraZeneca Shares Gain As Coronavirus Vaccine Trials Resume
AstraZeneca shares were trading at 8,431 pence by 0833 GMT. UK pharma stocks, however, underperformed the FTSE 100, with GSK down 0.2% and Hikma 1% on Trump's order.
Read More
AstraZeneca Pauses Coronavirus Vaccine Trial As Participant Illness Investigated
Germany's Leukocare, which is working on a vaccine similar to AstraZeneca's but at an earlier stage, agreed that safety issues are likely to crop up in large trials.
Read More
Weak Global Cues Drag Down Equity Indices, Banking Stocks Suffer
The BSE S&P Sensex closed 171 points or 0.45 per cent lower at 38,194 while the Nifty 50 was down by 39 points or 0.35 per cent at 11,278.
Read More
AstraZeneca Puts Leading COVID-19 Vaccine Trial On Hold Over Safety Concern
Shares of AstraZeneca fell more than 8% in after-hours U.S. trading, while shares of rival vaccine developers rose. Moderna Inc was up more than 4% and Pfizer Inc rose less than 1%.
Read More